Cholesterol Absorption Inhibitors

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
33:21

15th Annual Orange County Symposium for Cardiovascular Disease Prevention

Newer Recommendations, Therapies, and Evidence for Improving Lipid Control and Cardiovascular Outcomes

FEATURING Nathan Wong
  • 2,904 views
  • November 27, 2023
  • 19
06:23

Scripps Health

Familial Hypercholesterolemia, Dyslipidemia and Lipids: Panel Discussion

FEATURING David Cork, Norman Lepor, P. Barton Duell
  • 210 views
  • June 28, 2023
  • 1
24:26

Scripps Health

Non-HDL Targets for Risk Reduction

FEATURING David Cork
  • 1,041 views
  • June 28, 2023
  • 4
31:27

Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Novel Therapeutics

FEATURING Norman Lepor
  • 4,833 views
  • June 28, 2023
  • 48
39:44

The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and What the Future Holds

FEATURING Salim Virani
  • 5,480 views
  • January 5, 2023
  • 36
17:21

Canadian Collaborative Research Network

When to Use Ezetimibe or PCSK9 in Secondary Prevention

FEATURING Jacques Genest
  • 710 views
  • June 13, 2022
  • 1
10:36

Antonio Moschetta

2021 ADA Highlights: The Relationship Between Nuclear Receptor FXR, Gut Microbiota, and Metabolism

  • 11 views
  • July 14, 2021
06:38

Matthew Budoff

LDL Lowering and CV Risk: What to Consider When Working to Reduce Patients' LDL Cholesterol?

  • 253 views
  • December 3, 2020
  • 1
13:14

Houston Methodist DeBakey Heart and Vascular Center

Prevention of MIs and Stroke: How to Screen and Stratify Risks in the Young Before They Have an Event? Should We Start an Asymptomatic Patient on Statin Therapy?

FEATURING Salim Virani, Khurram Nasir, Haider Warraich, Ron Blankstein
  • 873 views
  • July 3, 2020
  • 1
15:34

Cleveland Clinic European Society of Cardiology 2016 Symposium

The Science of HDL and Reverse Cholesterol Transport

  • 844 views
  • September 16, 2016
  • 3
05:30

Cleveland Clinic Heart, Vascular and Thoracic Institute

Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High Risk for Vascular Outcomes - ACCELERATE Trial

FEATURING Steven Nissen
  • 825 views
  • July 26, 2016
  • 4

Recommended Topics:

PCSK9

All Topics: